Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 7, Issue 6, Pages 707-720
Publisher
Informa Healthcare
Online
2011-03-25
DOI
10.1517/17425255.2011.570330
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pegylated liposomal doxorubicin in the management of ovarian cancer
- (2016) Gabriella Ferrandina Therapeutics and Clinical Risk Management
- Phase II trial of biweekly pegylated liposomal doxorubicin in recurrent platinum-refractory ovarian and peritoneal cancer
- (2010) Hans-Georg Strauss et al. ANTI-CANCER DRUGS
- Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
- (2010) Lesley A Smith et al. BMC CANCER
- Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer
- (2010) B. L. Rapoport et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer
- (2010) Ignace Vergote et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
- (2010) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer
- (2010) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
- (2010) John J Kavanagh et al. Journal of Hematology & Oncology
- Pegylated liposomal doxorubicin (CAELYX®) in patients with advanced ovarian cancer: results of a German multicenter observational study
- (2009) Jalid Sehouli et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase 3 randomised study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer
- (2009) I. Vergote et al. EUROPEAN JOURNAL OF CANCER
- Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: A phase II study
- (2009) Patti Power et al. GYNECOLOGIC ONCOLOGY
- Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer
- (2009) Janos L. Tanyi et al. GYNECOLOGIC ONCOLOGY
- Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: A Multicenter Phase II Trial
- (2009) Florence Joly et al. GYNECOLOGIC ONCOLOGY
- A Phase I Study of Oral Topotecan and Pegylated Liposomal Doxorubicin (Doxil) in Platinum-Resistant Ovarian and Peritoneal Cancer
- (2008) Peter G. Rose et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
- (2008) M. von Mehren et al. ANNALS OF ONCOLOGY
- Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs
- (2008) Neil Ashley et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pegylated liposomal doxorubicin-associated hand–foot syndrome: Recommendations of an international panel of experts
- (2008) Roger von Moos et al. EUROPEAN JOURNAL OF CANCER
- A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer
- (2008) Faruk Tas et al. International Journal of Clinical Oncology
- Chemotherapy with pegylated liposomal doxorubicin and cisplatin in recurrent platinum-sensitive epithelial ovarian cancer
- (2008) Faruk Tas et al. International Journal of Clinical Oncology
- Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer
- (2008) Gabriella Ferrandina et al. JOURNAL OF CLINICAL ONCOLOGY
- Carboplatin and Pegylated Liposomal Doxorubicin for Advanced Ovarian Cancer: Preliminary Activity Results of the MITO-2 Phase III Trial
- (2008) S. Pignata et al. ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started